Close
Nordic 9Nordic 9

i&i Biotech Fund (investor - Others)

Luxembourg inibio.eu
See something wrong or missing? Let us know
Offices:Luxembourg

i&i Biotech Fund is a Luxembourg-based tech transfer fund focused on Life Sciences.

Average round investment:10.01M USD
Average number per year:2.5
Distribution: 2025 (3)2024 (2)2023 (2)2022 (3)
Portfolio companies: Germany T-curxGermany Captain T CellSpain Nanoligent See the entire list
Mostly invests in: Germany Germany (3) Biotech (8)
See the entire list

Showing 3 of 10 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to i&i Biotech Fund

Name Criteria
Germany Christian Vollmann
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Software Services, Manufacturing, AI (big data), Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Sweden Jacob De Geer
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Manufacturing, Electronics, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United Kingdom SynBioVen
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Germany Magnetic VC
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, Netherlands, United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Netherlands Stellantis
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Software Services, Manufacturing, Electronics, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United States Anatoly Yakovenko
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United Kingdom Saras Capital
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services, Manufacturing, Pharma, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United States Montage Ventures
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services, Manufacturing, Pharma, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Italy Ithaca Investments
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Software Services, Manufacturing, AI (big data), Electronics, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, Spain, United Kingdom
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
United Kingdom Concentric
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Top